Skip to main content
Skip to content
Case File
efta-01519389DOJ Data Set 10Other

EFTA01519389

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01519389
Pages
1
Persons
0
Integrity

Summary

Ask AI About This Document

0Share
PostReddit
Review This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GHISLAINE MAXWELL - OAP 1HD ACCT. For the Period 2/1/14 to 2/28/14 Equity Summary Asset Categories Beginning Ending Change Current Market Value Market Value In Value Allocation EAFE Equity 1,847,938.92 137 528 10 Market Value/Cost Current Penod Value Market Value 137,528.10 Tax Cost 132,686.12 Unrealized Gain/Loss 4,841.98 Estimated Annual Income 5,106.04 Accrued Dividends 12,566.34 Yield 3.71% Equity Detail (1,710,410.82) 100% Adjusted Tax Cost Unrealized Est. Annual Inc Pike Quantity Value Original Cost Gain/Loss Accrued Div. Yield EAFE Equity ASTRAZENECA PLC 67.76 0.00 4.13% SPONS ADR 824.15 046353.108 AZN GLAXOSINDIKUNE PLC 55.94 0.00 4 41% SPONS ADR 684.77 37733W-10.5 GSK JP Morgan Page 4 of 15 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00046675 SDNY_GM_00315873 EFTA01519389

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.